Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes

NCT00812578 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2010-07-12

No results posted yet for this study

Summary

The purpose of the study is to examine the effect on metabolic parameters after 12 weeks of treatment with high dose vitamin D in patients with type 2 diabetes and vitamin D insufficiency.

Conditions

Interventions

DRUG

Cholecalciferol

8 tablets equivalent to 280 micrograms for 2 weeks and 4 tablets equivalent to 140 micrograms for 10 weeks

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER
  • Regionshospitalet Silkeborg

    collaborator OTHER
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Lotte Oeskov, MD · Medical Department, Silkeborg Hospital, Falkevej 1-3, 8600 Silkeborg, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812578 on ClinicalTrials.gov